retatrutide latest clinical trial results Lilly's triple agonist achieves 16.8% weight loss in phase 3 Retatrutide Results: 24% Weight Loss

Dont panic about small fluctuations

When retatrutide drives 20 to 30 percent body weight reduction, that reduction is not neutral hormonally

Elizabeth Nooyen, PA-C Family Medicine Elizabeth Nooyen, PA-C ADHD Primary Care Weight Loss Elizabeth Nooyen, PA-C is a board-certified Physician Assistant with extensive clinical experience across primary care, dermatology, pediatrics, womens health, and internal medicine

GLP-1 patient trends: demographics and adherence patterns Usage across the population A nationally representative survey conducted by RAND found that 11.8% of Americans have used GLP-1 drugs for weight loss, and about 14% express interest, while 74% say they do not plan to take them

And as long as it's continued to completion, I don't think efficacy is really a question at this point either. However, lower dosing often means a longer treatment course